[A therapeutic protocol with cefoperazone in bronchopneumopathy in mucoviscidosis].

Cystic fibrosis, a hereditary chronically evolving disease, is characterized by special predisposition to bronchial infections, especially by Pseudomonas strains. In the present open noncomparative study, the therapeutic efficacy of cefoperazone in respiratory infections by Pseudomonas aeruginosa in 25 children suffering from cystic fibrosis has been evaluated. Results were favorable, since both the specific symptoms of the infection and the general condition of the patients was markedly improved although the eradication of Pseudomonas was not achieved.